{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:34:22Z","timestamp":1790264062110,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:00:00Z","timestamp":1505520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"AbbVie (Spain)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00296-017-3814-2","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T06:52:02Z","timestamp":1505544722000},"page":"1817-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study)"],"prefix":"10.1007","volume":"37","author":[{"given":"Agust\u00ed","family":"Sellas i Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Juanola Roura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Alonso Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Medina Luezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Collantes Estevez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Abad Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Carrasco Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Fisac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"issue":"12","key":"3814_CR1","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"5","key":"3814_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/rheumatology\/keh549","volume":"44","author":"KL Haywood","year":"2005","unstructured":"Haywood KL, Garratt AM, Dawes PT (2005) Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford) 44(5):577\u2013586","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3814_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20075","volume":"51","author":"AJ Wanders","year":"2004","unstructured":"Wanders AJ, Gorman JD, Davis JC, Landewe RB, van der Heijde DM (2004) Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis. Arthritis Rheum 51(1):1\u20138","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3814_CR4","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"4","key":"3814_CR5","first-page":"997","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, de Vlam K, van der Heijde D, de Klerk E, Dougados M, Mielants H et al (1999) Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over 1\u00a0year. J Rheumatol 26(4):997\u20131002","journal-title":"J Rheumatol"},{"issue":"1","key":"3814_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18\u201324","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3814_CR7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811\u20131818","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3814_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrrheum.2013.93","volume":"9","author":"P Machado","year":"2013","unstructured":"Machado P, Landewe R (2013) Spondyloarthritis: is it time to replace BASDAI with ASDAS? Nat Rev Rheumatol 9(7):388\u2013390","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"3814_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"3814_CR10","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/S1699-258X(07)73645-8","volume":"3","author":"E Collantes","year":"2007","unstructured":"Collantes E, Fern\u00e1ndez Sueiro JL, Garc\u00eda-Vicu\u00f1a R, Gratac\u00f3s J, Mulero J, Mu\u00f1oz Fern\u00e1ndez S, Sanmart\u00ed R, Zarco P, Angel Abad M, Batlle E, de Dios Ca\u00f1ete J, Gonz\u00e1lez Crespo MR, Gonz\u00e1lez C, Juanola X, Sanz J, Rivera J (2007) Actualizaci\u00f3n del Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre el uso de antagonistas del TNF\u03b1 en las espondiloartritis, incluida la artritis psori\u00e1sica. Reumatol Clin 3(Suppl 2):S60\u2013S70. doi:\n                        10.1016\/S1699-258X(07)73645-8\n                        \n                     (Article in Spanish)","journal-title":"Reumatol Clin"},{"issue":"12","key":"3814_CR11","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"4","key":"3814_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/art.11197","volume":"49","author":"R Ariza-Ariza","year":"2003","unstructured":"Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49(4):483\u2013487","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3814_CR13","first-page":"1694","volume":"21","author":"TR Jenkinson","year":"1994","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694\u20131698","journal-title":"J Rheumatol"},{"issue":"6","key":"3814_CR14","first-page":"372","volume":"31","author":"R Ariza-Ariza","year":"2004","unstructured":"Ariza-Ariza R, Hern\u00e1ndez-Cruz B, Navarro-Sarabia F (2004) La versi\u00f3n espa\u00f1ola del BASDAI es fiable y se correlaciona con la actividad de la enfermedad en pacientes con espondilitis anquilosante. Rev Esp Reumatol 31(6):372\u2013378","journal-title":"Rev Esp Reumatol"},{"issue":"1","key":"3814_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1037\/0033-2909.111.1.172","volume":"3","author":"XL Meng","year":"1992","unstructured":"Meng XL, Rosenthal R, Rubin DR (1992) Comparing correlated correlation coefficients. Psychological Bull 3(1):172\u2013175","journal-title":"Psychological Bull"},{"issue":"5","key":"3814_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman DD (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53(5):459\u2013468","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"3814_CR17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3899\/jrheum.110279","volume":"38","author":"PM Machado","year":"2011","unstructured":"Machado PM, Landewe RB, van der Heijde DM (2011) Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10. J Rheumatol 38(7):1502\u20131506","journal-title":"J Rheumatol"},{"key":"3814_CR18","first-page":"52","volume":"77","author":"FFV Lekpa","year":"2010","unstructured":"Lekpa FFV, Claudepierre P (2010) Response criteria in spondylarthropathies: definition of a responder. Rev Rhum Monogr 77:52\u201358","journal-title":"Rev Rhum Monogr"},{"issue":"6","key":"3814_CR19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Sorensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS et al (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69(6):1065\u20131071","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3814_CR20","first-page":"752","volume":"28","author":"SZ Aydin","year":"2010","unstructured":"Aydin SZ, Can M, Atagunduz P, Direskeneli H (2010) Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol 28(5):752\u2013755","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"3814_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","volume":"44","author":"A Spoorenberg","year":"2005","unstructured":"Spoorenberg A, van Tubergen A, Landewe R, Dougados M, van der Linden S, Mielants H et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44(6):789\u2013795","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3814_CR22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2012-202976","volume":"73","author":"C Fernandez-Espartero","year":"2014","unstructured":"Fernandez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA et al (2014) Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis 73(7):1350\u20131355","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3814_CR23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00296-014-3168-y","volume":"35","author":"E Kilic","year":"2015","unstructured":"Kilic E, Kilic G, Akgul O, Ozgocmen S (2015) Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study. Rheumatol Int 35(6):981\u2013989","journal-title":"Rheumatol Int"},{"issue":"3","key":"3814_CR24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-014-2734-8","volume":"34","author":"G Kilic","year":"2015","unstructured":"Kilic G, Kilic E, Nas K, Karkucak M, Capkin E, Dagli AZ et al (2015) Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis. Clin Rheumatol 34(3):515\u2013521","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3814-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3814-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3814-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T08:19:54Z","timestamp":1508228394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3814-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3814"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3814-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]}}}